JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Transuranium Elements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/15439

Title: Sequential Cytarabine and a-Particle Immunotherapy with Bismuth-213¿Lintuzumab (HuM195) for Acute Myeloid Leukemia
Authors: ROSENBLAT Todd
MCDEVITT Michael
MULFORD D.a.
PANDIT-TASKAR N.
DIVGI C.r.
PANAGEAS Katherine
HEANEY M. L.
CHANEL S.
MORGENSTERN Alfred
SGOUROS George
LARSON S. M.
SCHEINBERG D. A.
JURCIC J. G.
Citation: CLINICAL CANCER RESEARCH vol. 16 no. 21 p. 5303-5311
Publisher: AMER ASSOC CANCER RESEARCH
Publication Year: 2010
JRC Publication N°: JRC61749
ISSN: 1078-0432
URI: http://publications.jrc.ec.europa.eu/repository/handle/111111111/15439
DOI: 10.1158/1078-0432.CCR-10-0382
Type: Articles in Journals
Appears in Collections:Institute for Transuranium Elements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top